Delivery Order SPE2DB20D2014-SPE2DB25FB09V

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication, with a firm fixed price ceiling value of $1,467.09 and an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a specialty medication, with a ceiling value of $13,987.53 and a period of performance through November 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,237.82, is for the delivery of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of March 5, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a cardiovascular medication. The contract has a ceiling value of $18,330.04 and runs through February 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for the product "REPATHA 140 MG/ML SURECLICKML" with a ceiling value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,101.05 Firm Fixed Price Delivery Order is for the supply of REPATHA 140 MG/ML SURECLICK, a pharmaceutical product. The contract has an ultimate completion date of May 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract has a ceiling value of $26,107.16 and a completion date of March 8, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,111.53 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a cardiovascular medication, with a completion date of May 17, 2023. This award is a discrete delivery order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product REPATHA 140 MG/ML SURECLICK. The contract has a completion date of January 30, 2024 and a potential value of $1,525.23. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK ML, a specialty medication. The contract has a ceiling value of $5,028.40 and runs through June 12, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB09V
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICK medical supplies, with a ceiling value of $5,124.58 and a period of performance through February 2025.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition.

Generated 5/20/25, 2:18 PM